Clinical Trial Update: Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating short-term Motilitone therapy effects on quality of life in Parkinson disease patients with gastrointestinal symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Parkinson Disease

Drugs mentioned

• Motilitone

Snippet

Sponsor: Seoul National University Hospital | Conditions: Parkinson Disease, Dyspepsia | Phase 4 | Status: COMPLETED